A randomized double-blind study comparing the efficacy and safety of orlistat versus placebo in obese patients with mild to moderate hypercholesterolemia.
de Castro
João Jácome
JJ
S. Endocrinologia, Hospital Militar Principal, Coimbra, Portugal. endoc.hmp@sapo.pt
Dias
Teresa
T
Chambel
Paula
P
Carvalheiro
Manuela
M
Correia
Luís Gardette
LG
Guerreiro
Liliana
L
Marques
Olinda
O
Medina
José Luís
JL
Nobre
Ema
E
Nunes
José Silva
JS
Pereiraa
Maria Carlos
MC
Polónia
Jorge
J
Portugal
Jorge
J
Raimundo
Anabela
A
Ruas
Almeida
A
da Silva
Pedro Marques
PM
Vasconcelos
Carlos
C
Reis
José Lima
JL
Teles
Alberto Galvão
AG
D000293:Adolescent; D000328:Adult; D000368:Aged; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications*; D007783:Lactones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D000077403:Orlistat; D012720:Severity of Illness Index; D014280:Triglycerides / Q000097:blood; D055815:Young Adult
D019440:Anti-Obesity Agents; D007783:Lactones; D014280:Triglycerides; D000077403:Orlistat; D002784:Cholesterol